RxDoctor Payments Data

Mumtaz Mohidin

Endocrinology, Diabetes & Metabolism · Babylon, NYNPI 1689625253

Payments from drug & device makers

$1,701in general payments, 2019–2025

Across 100 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$397
  • Sanofi-aventis U.S. LLC$291
  • Mannkind Corporation$202
  • Amneal Pharmaceuticals LLC$133
  • AbbVie$108
  • Abbott$85
  • plus $485 from 11 others

What the payments were for

  • Food & beverage$1,701100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,701 in reported general payments places this provider in the 50th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York

Other endocrinology, diabetes & metabolism in Babylon

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →